EFAVIRENZ | A077673 | AUROBINDO PHARMA LTD
Total Spending
$6.9M
Total Claims
12,645
Beneficiaries
1,779
Avg Cost/Unit
$12.77
Spending Trend
Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.
11 active API suppliers hold Drug Master Files for this ingredient.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
| Date | Submission | Document |
|---|---|---|
| Jun 29, 2005 | ORIG -1 | View Letter (PDF) |
Source: Drugs@FDA application documents.
No patent or exclusivity listings for this strength.